Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Science Translational Medicine|November 10, 2017
Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAHAtze van der Pol, Andres Gil, Herman H W Silljé, et al.
Nature Communications|March 12, 2016
CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDLPaulina Bartuzi, Daniel D Billadeau, Robert Favier, et al.
Molecular Biology of the Cell|October 31, 2014
COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7AChristine A Phillips-Krawczak, Amika Singla, Petro Starokadomskyy, et al.
Molecular Cell|May 7, 2016
The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine Aggregation and the Onset of Disease in a Mouse ModelVaishali Kakkar, Cecilia Månsson, Eduardo P de Mattos, et al.
Nature Communications|July 1, 2022
T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged miceVenetia Bazioti, Anouk M La Rose, Sjors Maassen, et al.
Life Science Alliance|May 2, 2023
Deletion of SERF2 in mice delays embryonic development and alters amyloid deposit structure in the brainEsther Stroo, Leen Janssen, Olga Sin, et al.
Disease Models & Mechanisms|January 10, 2016
The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers: a new canine model for copper-metabolism disordersHille Fieten, Yadvinder Gill, Alan J Martin, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretionWillemien van Zwol, Antoine Rimbert, Justina C Wolters, et al.
Gastroenterology|April 15, 2014
Copper metabolism domain-containing 1 represses genes that promote inflammation and protects mice from colitis and colitis-associated cancerHaiying Li, Lillienne Chan, Paulina Bartuzi, et al.
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
Pageof 11